Jess started her undergraduate degree at the University of Liverpool in 2013, specialising in Medicinal Chemistry and Pharmacology. Throughout Jess’s degree, she undertook 3 research projects; with two projects focussing on antimalarial drug development and one focussed on the treatment of tuberculosis.

​

Jess graduated in 2017 achieving a first-class master’s degree (MCHEM) and was also awarded the Syngenta prize for pharmacology. Following this, she carried out a PhD (2017-2021) in the McDonald group at the University of Liverpool, in partnership with Liverpool Women’s Hospital, exploring the development of nanoformulations for the prevention of sudden preterm birth. 

​

Jess joined the Rannard group specialising in formulation chemistry and the creation of industrially-relevant formulations funded by Tandem Nano Ltd and later took a role at the Royal Liverpool University Hospital to facilitate human drug trials and communication with patients and clinicans.